Related Experiment Video
Updated: Feb 12, 2026

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells
Maitham A Khajah1, Princy M Mathew1, Yunus A Luqmani1
1Faculty of Pharmacy, Kuwait University, Safat, Kuwait.
Background:
The Na+/K+-ATPase (NKP) is an important ion transporter also involved in signal transduction. Its expression profile is altered in various tumours including that of the breast. We studied the effect of inhibiting NKP activity in non-tumorigenic breast cell line and in estrogen receptor positive and negative breast cancer cells.
Methods:
Expression and localization of NKP and downstream signaling molecules were determined by RT-PCR, western blotting and immunofluorescence. Cell proliferation, apoptosis and cell cycle stage were determined using MTT, annexin V and flow cytometry. Cell motility and invasion were determined using wound healing and matrigel assays. Total matrix metalloproteinase (MMP) was determined by a fluorescence-based assay.
Results:
NKP was mainly localized on the cell membrane. Its baseline expression and activity were enhanced in breast cancer compared to the non-tumorigenic breast cell line. Ouabain and 3,4,5,6-tetrahydroxyxanthone (TTX) treatment significantly inhibited NKP activity, which significantly reduced cell proliferation, motility, invasion and pH-induced membrane blebbing. EGF stimulation induced internalization of NKP from the cell membrane to the cytoplasm. Ouabain inhibited EGF-induced phosphorylation of Rac/cdc42, profillin, ERK1/2 and P70S6K.
Conclusions:
The NKP may offer a novel therapeutic target in breast cancer patients who have developed metastasis, aiming to improve therapeutic outcomes and enhance survival rate.
Insights
Inhibiting the Na+/K+-ATPase (NKP) in breast cancer cells reduced proliferation, motility, and invasion. Targeting NKP may offer a new therapeutic strategy for metastatic breast cancer.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- The Na+/K+-ATPase (NKP) is a crucial ion transporter implicated in signal transduction.
- Altered NKP expression is observed in various cancers, including breast cancer.
- This study investigates NKP inhibition in non-tumorigenic and breast cancer cell lines.
Purpose of the Study:
- To evaluate the impact of inhibiting NKP activity on breast cancer cell behavior.
- To explore NKP as a potential therapeutic target in breast cancer, particularly in metastatic cases.
- To analyze the effects of NKP inhibition on cell proliferation, motility, invasion, and signaling pathways.
Main Methods:
- Utilized RT-PCR, western blotting, and immunofluorescence for expression and localization analysis.
- Assessed cell proliferation, apoptosis, and cell cycle via MTT, annexin V, and flow cytometry.
- Quantified cell motility, invasion, and matrix metalloproteinase activity using wound healing, matrigel, and fluorescence assays.
Main Results:
- NKP was primarily located on the cell membrane, with enhanced baseline expression and activity in breast cancer cells.
- Ouabain and TTX treatment significantly inhibited NKP activity, reducing proliferation, motility, invasion, and membrane blebbing.
- EGF stimulation caused NKP internalization, and ouabain inhibited downstream signaling pathways including Rac/cdc42, ERK1/2, and P70S6K.
Conclusions:
- NKP activity is elevated in breast cancer and contributes to aggressive phenotypes.
- Inhibiting NKP demonstrates significant anti-cancer effects on proliferation and metastasis.
- Targeting NKP presents a promising therapeutic avenue for improving outcomes in metastatic breast cancer patients.
Related Concept Videos
Endocrine Signaling
Treatment Resistant Cancers
What is the Endocrine System?
The Endocrine System
An Overview of the Endocrine System
The endocrine system collaborates...
Structures of the Endocrine System

